Clinical Trials Browser

Phase 3 × OTHER × 130-nm albumin-bound paclitaxel × Clear all

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult

NCT03774732 2026-02-25

NIRVANA-LUNG

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06958328 2026-02-02

LAP100

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05624996 2026-01-14

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Phase 3 Recruiting

Lung Neoplasms

NCT07272109 2025-12-15

PTCA199-16

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT02514681 2025-09-10

PRECIOUS

Phase 3 Completed

Breast Neoplasms

NCT07155629 2025-09-04

LEFT-PANC

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Resectable

NCT06018883 2025-08-07

PTCA199-3

Phase 3 Active not recruiting

Classical hematology

Anemia

NCT06250972 2025-08-07

PTCA199-11

Phase 3 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT07062263 2025-07-14

TAB-2

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT04085276 2025-06-11

TORCHLIGHT

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT03750669 2025-05-13

Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02344472 2024-06-04

Detect V / CHEVENDO (Chemo vs. Endo)

Phase 3 Active not recruiting

Breast Neoplasms

NCT01822314 2024-03-07

ETNA

Phase 3 Completed

Breast Neoplasms, Neoplasms

NCT05178628 2022-03-29

imPaCT-PRO

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT04768075 2021-02-24

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01690702 2021-02-02

GAIN-2

Phase 3 Completed

Breast Neoplasms

NCT01583426 2020-08-06

GeparSepto

Phase 3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT02506842 2016-08-11

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms